Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FFCX7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,518
Award facts
- Contract value 100% obligated
- $33,517.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards $33,517.87 to AmerisourceBergen Drug Corp for the supply of KESIMPTA (ofatumumab) 20 mg/0.4 mL auto-injector pens under a firm fixed price arrangement. The contract was awarded by the Defense Logistics Agency (DLA) on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. KESIMPTA is a monoclonal antibody indicated for the treatment of relapsing multiple sclerosis, reflecting the pharmaceutical distributor's role in supplying specialty medications to support federal healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle running through December 2026 that provides comprehensive global pharmaceutical support. The IDC enables AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills federal medical supply needs through competitively awarded contracts encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FFCX7?
SPE2DB25FFCX7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FFCX7 worth?
The government has obligated $33,518 on SPE2DB25FFCX7.
Is contract SPE2DB25FFCX7 an order under another contract?
Yes. SPE2DB25FFCX7 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFCX7 competed?
The extent of competition for SPE2DB25FFCX7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award